2005
DOI: 10.1016/j.jinf.2005.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Invasive candidiasis in cancer patients: observations from a randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
33
1

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(39 citation statements)
references
References 35 publications
5
33
1
Order By: Relevance
“…Our patient population consisted of 60 individuals with seven different types of cancers. Gastro-intestinal cancer and Breast cancer were the most frequent cancer in the studied group, accounting for 65 % and 18.4 % respectively which is in accordance to other investigation [12]. Results obtained in this study established several points pertinent to the prevalence of oral candidiasis consistent with published data [13][14].…”
Section: Discussionsupporting
confidence: 91%
“…Our patient population consisted of 60 individuals with seven different types of cancers. Gastro-intestinal cancer and Breast cancer were the most frequent cancer in the studied group, accounting for 65 % and 18.4 % respectively which is in accordance to other investigation [12]. Results obtained in this study established several points pertinent to the prevalence of oral candidiasis consistent with published data [13][14].…”
Section: Discussionsupporting
confidence: 91%
“…In general, compared with patients with solid tumors, patients with hematologic malignancies are at increased risk for fungal disease and response to IFI treatment is lower [10]. A 1992 international autopsy survey of patients with cancer identified fungal infections in 25% of patients with leukemia, 12% with lymphoma, and 5% with solid tumors.…”
Section: Nih Public Accessmentioning
confidence: 99%
“…In addition, invasive aspergillosis (IA) surpassed invasive candidiasis (IC) as the most common IFI encountered in the HSCT population: Aspergillus accounted for 43% of infections and Candida accounted for 28%, followed by There are no recent, multicenter studies describing the incidence and clinical outcome of IFIs among the general oncology population and it is difficult to obtain an accurate estimate of the frequency of fungal infections in this population from the published literature as most reports do not provide sufficient information regarding the patients' underlying disease. In general, compared with patients with solid tumors, patients with hematologic malignancies are at increased risk for fungal disease and response to IFI treatment is lower [10]. A 1992 international autopsy survey of patients with cancer identified fungal infections in 25% of patients with leukemia, 12% with lymphoma, and 5% with solid tumors.…”
Section: Epidemiology Of Invasive Fungal Infectionsmentioning
confidence: 99%
“…Previous studies showed that invasive candidiasis is a common and serious complication of cancer and its therapy (5). In cancer patients, it has been hypothesized that it develops from initial gI colonization with subsequent translocation into the bloodstream.…”
Section: Introductionmentioning
confidence: 99%